You have to be logged in to add this to Watchlist.Natco Pharma is trading 0.76% upper at Rs 790.90 as compared to its last closing price. Natco Pharma has been trading in the price range of 807.85 & 789.00. Natco Pharma has given 39.84% in this year & -0.49% in the last 5 days.
Natco Pharma has TTM P/E ratio 14.00 as compared to the sector P/E of 23.05.There are 13 analysts who have initiated coverage on Natco Pharma. There are 2 analysts who have given it a strong buy rating & 4 analysts have given it a buy rating. 2 analysts have given the stock a sell rating.
The company posted a net profit of 369.00 Crores in its last quarter.
Listed peers of Natco Pharma include Piramal Pharma (-0.28%), Alembic Pharmaceuticals (0.09%), Natco Pharma (0.76%) etc.
Natco Pharma has a 49.71% promoter holding & 50.29% public holding.The Mutual Fund holding in Natco Pharma was at 6.34% in 30 Sep 2023. The MF holding has increased from the last quarter. The FII holding in Natco Pharma was at 12.82% in 30 Sep 2023. The FII holding has increased from the last quarter.
Natco Pharma share price range
|
| ||||
|
| ||||
Natco Pharma share Key Metrics
| Market Cap ( ₹ Cr.) | 14,067.29 | ||||||||||||||||||
|
|
Natco Pharma share price news
Natco Pharma share price Today Live Updates : Natco Pharma's Stock Soars on Positive Trading Day
13 min read .06:17 PM IST
Natco Pharma Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 14-Nov-23 | Quarterly Results & Interim Dividend |
| 09-Aug-23 | Quarterly Results & Interim Dividend |
| 29-May-23 | Audited Results |
| 08-Mar-23 | Buy Back of shares |
| 09-Feb-23 | Quarterly Results & Interim Dividend |
| 10-Nov-22 | Quarterly Results & 2nd Interim Dividend |
| 09-Aug-22 | Quarterly Results & Interim Dividend |
| 30-May-22 | Audited Results |
| 14-Feb-22 | Quarterly Results & 3rd Interim Dividend |
| 11-Nov-21 | Quarterly Results & Interim Dividend |
| Meeting Date | Announcement On | Purpose |
| 27-Mar-22 | 22-Feb-22 | POM |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 15-Nov-23 | 24-Nov-23 | 24-Nov-23 | 1.25 |
| 09-Aug-23 | 22-Aug-23 | 22-Aug-23 | 7 |
| 09-Feb-23 | 21-Feb-23 | 21-Feb-23 | 1.25 |
| 10-Nov-22 | 22-Nov-22 | 21-Nov-22 | 0.75 |
| 10-Aug-22 | 22-Aug-22 | 19-Aug-22 | 3.5 |
| 14-Feb-22 | 25-Feb-22 | 24-Feb-22 | 2 |
| 11-Nov-21 | 24-Nov-21 | 23-Nov-21 | 0.5 |
| 12-Aug-21 | 25-Aug-21 | 24-Aug-21 | 2 |
| 11-Feb-21 | 23-Feb-21 | 22-Feb-21 | 1 |
Market Live Updates
FAQs about Natco Pharma share price
Natco Pharma is trading at 790.90 as on Mon Dec 04 2023 09:59:01. This is 0.76% upper as compared to its previous closing price of 784.90.
The market capitalization of Natco Pharma is 14165.80 Cr as on Mon Dec 04 2023 09:59:01.
The average broker rating on Natco Pharma is Hold. The breakup of analyst rating is given below -
- 2 analysts have given a strong buy rating
- 4 analysts have given a buy rating
- 4 analysts have given a hold rating
- 2 analysts have given a sell rating
- 1 analysts have given a strong sell rating
The 52 wk high for Natco Pharma is 928.45 whereas the 52 wk low is 502.00
Natco Pharma can be analyzed on the following key metrics -
- TTM P/E: 14.00
- Sector P/E: 23.05
- Dividend Yield: 1.21%
- D/E ratio: 0.05
Natco Pharma reported a net profit of 715.30 Cr in 2023.
Natco Pharma Quick Links
Natco Pharma Dividend | Natco Pharma Bonus | Natco Pharma News | Natco Pharma AGM | Natco Pharma Rights | Natco Pharma Splits | Natco Pharma Board Meetings | Natco Pharma Key Metrics | Natco Pharma Shareholdings | Natco Pharma Profit Loss | Natco Pharma Balance Sheet | Natco Pharma Cashflow | Natco Pharma Q1 Results | Natco Pharma Q2 Results | Natco Pharma Q3 Results | Natco Pharma Q4 Results
Equity Quick Links
Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks
